Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s42399-021-00874-8 http://scihub22266oqcxt.onion/10.1007/s42399-021-00874-8 33898925!8057921!33898925     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       SN+Compr+Clin+Med 2021 ; 3 (7): 1484-1501 Nephropedia Template TP {{tp|p=33898925|t=2021. Repositioned Drugs for COVID-19-the Impact on Multiple Organs |pdf=|usr=}}{{33898925}} gab.com Text Repositioned Drugs for COVID-19-the Impact on Multiple Organs JO: SN Compr Clin Med http://www.kidney.de/pget.php?&tw=1&pmid=33898925 #FOAvip This review summarizes published findings of the beneficial and harmful effects on the heart, lungs, immune system, kidney, liver, and central nervous system of 47 drugs that have been proposed to treat COVID-19. Many of the repurposed drugs were chosen for their benefits to the pulmonary system, as well as immunosuppressive and anti-inflammatory effects. However, these drugs have mixed effects on the heart, liver, kidney, and central nervous system. Drug treatments are critical in the fight against COVID-19, along with vaccines and public health protocols. Drug treatments are particularly needed as variants of the SARS-Cov-2 virus emerge with some mutations that could diminish the efficacy of the vaccines. Patients with comorbidities are more likely to require hospitalization and greater interventions. The combination of treating severe COVID-19 symptoms in the presence of comorbidities underscores the importance of understanding the effects of potential COVID-19 treatments on other organs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s42399-021-00874-8. Twit Text FOAVip Repositioned Drugs for COVID-19-the Impact on Multiple Organs ????SN Compr Clin Med http://www.kidney.de/pget.php?&tw=1&pmid=33898925 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33898925 #FOAvip English Wikipedia <ref>{{Cite pmid|33898925}}</ref> Repositioned Drugs for COVID-19-the Impact on Multiple Organs #MMPMID33898925 Chan C; Foster ST; Chan KG; Cacace MJ; Ladd SL; Sandum CT; Wright PT; Volmert B; Yang W; Aguirre A; Li W; Wright NT SN Compr Clin Med 2021[]; 3 (7): 1484-1501 PMID33898925show ga This review summarizes published findings of the beneficial and harmful effects on the heart, lungs, immune system, kidney, liver, and central nervous system of 47 drugs that have been proposed to treat COVID-19. Many of the repurposed drugs were chosen for their benefits to the pulmonary system, as well as immunosuppressive and anti-inflammatory effects. However, these drugs have mixed effects on the heart, liver, kidney, and central nervous system. Drug treatments are critical in the fight against COVID-19, along with vaccines and public health protocols. Drug treatments are particularly needed as variants of the SARS-Cov-2 virus emerge with some mutations that could diminish the efficacy of the vaccines. Patients with comorbidities are more likely to require hospitalization and greater interventions. The combination of treating severe COVID-19 symptoms in the presence of comorbidities underscores the importance of understanding the effects of potential COVID-19 treatments on other organs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s42399-021-00874-8. äRepositioned Drugs for COVID-19-the Impact on Multiple Organs (epmc).pdf DeepDyve Pubget Overpricing